Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?

Basit Öğe Kaydı
dc.contributor.authorTurker, P.
dc.contributor.authorEkici, Sinan
dc.date.accessioned2024-07-12T21:40:54Z
dc.date.available2024-07-12T21:40:54Z
dc.date.issued2012en_US
dc.department[Belirlenecek]en_US
dc.description.abstractAim: Bacillus Calmette-Guerin (BCG) is a standard treatment for reducing tumour recurrence and delaying progression of highrisk, non-muscle-invasive bladder tumours. However, it is not clear yet which patients are more likely to be responders to BCG. New Findings: The host factors and the tumor characteristics failed to be an independent factor in the prediction of BCG affectivity in the treatment of non-muscle invasive bladder cancer. The local immune response after intravesical BCG installation was studied meticulously and the predictive value of the elements in this pathway was determined. Among these urine levels of IL-2 has most encouraging results and also the determination of nucleotide polymorphisms of different cytokines in the inflammatory pathway seem promising. Results: Research continues to determine which patients would benefit from BCG treatment and also to establish a better outcome. New approaches are needed in the light of developments in biomedical technology. A very critical part of this therapy is to find out the correlation of different cytokines with BCG therapy, which will give a better insight not only the mechanism but also a better therapeutic options.en_US
dc.identifier.endpage51en_US
dc.identifier.issn2147-2270
dc.identifier.issue1en_US
dc.identifier.startpage46en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/7544
dc.identifier.volume11en_US
dc.identifier.wosWOS:000219391000010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofUroonkoloji Bulteni-Bulletin of Urooncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY09391
dc.subjectBacillus Calmette-Guerinen_US
dc.subjectBladder Canceren_US
dc.subjectPrognosisen_US
dc.titleIs it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?en_US
dc.typeReview Article
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu